COST ANALYSIS STUDY OF ORAL ANTIDIABETIC DRUGS AVAILABLE IN INDIAN MARKET
Journal Title: International Journal of Medical Research & Health Sciences (IJMRHS) - Year 2013, Vol 2, Issue 1
Abstract
Introduction: There exists a wide range of variation in the prices of drugs marketed in India and other countries of the world. Very few studies have been conducted to reveal such price variations in the open market. Aim & Objectives: To evaluate the cost of oral anti-diabetics of different generic classes and different brand names of one compound, To evaluate the difference in cost of different brands for the same active drug by calculating percentage variation of cost. Methods: Cost of a particular drug being manufactured by different companies, in the same strength, number and dosage form was compared. The difference in the maximum and minimum price of the same drug manufactured by different pharmaceutical companies and the percentage variation in price was calculated. Results: In Single drug therapy, among sulfonylurea group of drugs, Glimepiride (1 mg) shows maximum price variation of 655.38%, while Glipizide (10mg) shows variation of 38.88%. In Biguanides & Thizolidinediones groups of drugs, Metformin (500 mg) & Pioglitazone (15 mg) show maximum price variation of 308.33% & 542% respectively. In α-glucosidases inhibitor group of drugs, Miglitol shows maximum price variation of 135.50 %. In combination therapies, Glipizide & Metformin combination shows the maximum variation up to 399.04 %. Conclusion: The average percentage price variation of different brands of the same drug manufactured in India is very wide and the appraisal and management of marketing drugs should be directed toward maximizing the benefits of therapy and minimizing negative personal and economic consequences.
Authors and Affiliations
Nisharani B Jadhav| Department of pharmacology, B. L. D. E. U.’s S B M Patil Medical College, Bijapur, Karnataka, India corresponding author email: drnishajadhav@gmail.com, Manisha S Bhosale| Department of Pharmacology, Topiwala National Medical College and B. Y. L. Nair Charitable Hospital, Mumbai-Central, Mumbai, Maharashtra, India. 400008, Charles V Adhav| Department of Pharmacology, Topiwala National Medical College and B. Y. L. Nair Charitable Hospital, Mumbai-Central, Mumbai, Maharashtra, India. 400008
Keywords
Related Articles
- EP ID EP10952
- DOI -
- Views 430
- Downloads 22
Prevalence of Genital Tuberculosis among Infertile Women: A Systematic Review and Meta-analysis
Genital tuberculosis is a kind of infectious diseases with a relatively high prevalence in developing countries. The aim of this study was to investigate the prevalence of genital tuberculosis among infertile women. A P...
RECURRENT CORNUAL ECTOPIC PREGNANCY – A CASE REPORT
Cornual ectopic gestation is one of the causes of “Maternal near miss†cases. In the modern era of IVF treatments and better imaging techniques, more number of cases of cornual ectopic pregnancies is being diagnose...
Effect of urinary tract infection on the urinary metabolic characteristic as a risk factor in producing urolithiasis
Urinary metabolic disorders are one of the most common causes of stone formation in children. The purpose of this study was to evaluate the effect of urinary tract infections in the urinary metabolic characteristics as...
Coagulation profile in normal full-term neonate in the first week of life in Lagos-Nigeria
Normal reference values of haemostatic profile are frequently needed to assist in diagnosis and management of bleeding disorders. Because of the anatomical and physiological differences between neonates and adults, it i...
Study on hepatitis B vaccination coverage among workforce of a tertiary care hospital in North India
Hepatitis B is one of the most serious of the 20 blood borne pathogens which are the major threat to health care workers (HCWs). While a vaccine for hepatitis B exists, its utilization among HCWs and factors surrounding...